PMH14 COST-EFFECTIVENESS ANALYSIS OF GALANTAMINE (REMINYL ER) IN THE TREATMENT OF MILD TO MODERATE DEMENTIA OF THE ALZHEMIER'S TYPE IN MEXICO
May 1, 2007, 00:00
10.1016/S1098-3015(10)68767-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)68767-0/fulltext
Title :
PMH14 COST-EFFECTIVENESS ANALYSIS OF GALANTAMINE (REMINYL ER) IN THE TREATMENT OF MILD TO MODERATE DEMENTIA OF THE ALZHEMIER'S TYPE IN MEXICO
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)68767-0&doi=10.1016/S1098-3015(10)68767-0
First page :
Section Title :
Open access? :
No
Section Order :
549